International FY23 highlights

CDMO revenues increased >50% on FY22 largely attributable to new third
party contract sales in 2H following divestment of US Retail Generics

12m investment in partnership with the Australian Government who
provided an $4.8m grant under their Modern Manufacturing Initiative
(MMI) program improves capabilities and efficiencies in the Salisbury
facility
● CDMO revenues increased >50% on FY22 largely attributable to new third
party contract sales in 2H following divestment of US Retail Generics
● MPA revenues increased 7% on FY22 with in licensed product growth of
26% attributable to new product launches and growth in existing product
portfolio